Bionovo Inactive 10-Q2009 Q1 Quarterly report

Filed: 7 May 09, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: altogether, antidilutive, APB, approach, awaiting, biopharmaceutical, certainty, chemotherapy, chose, cohort, conceived, diagnosed, dissolution, encouraging, enhance, expenditure, factored, forfeiture, impracticable, isolate, Jim, MenerbaTM, nonclinical, pretreated, prove, purify, reach, shareholder, specialist, transition, yield

Removed: absence, accessed, adjusted, adjustment, advance, amendment, annually, applied, approximate, ARB, assessing, assumed, attempt, attributable, attribute, book, Bulletin, call, capitalization, cease, chemistry, collateral, computed, computer, contracted, controlling, convertible, cook, corroborated, deferral, delivered, dependent, derecognition, derivative, derive, directly, discontinued, dividing, drawdown, driven, duly, EITF, Electric, emerging, Emeryville, entered, entirety, evaluating, exceeding, exit, expensing, explore, face, FIN, financed, force, framework, frequently, furniture, GE, goodwill, hedged, hedging, identical, indirectly, interpretation, intrinsic, irrevocable, issue, July, leased, leasehold, leaving, letter, loan, location, Lynch, manner, maximize, menopausal, Merrill, minimize, modulator, NIH, noncontrolling, nonrefundable, noted, notice, November, observable, offering, orally, orderly, parent, pattern, payroll, permitted, PIPE, portion, post, principal, prospective, prospectively, publishing, recharacterized, reference, referred, reform, retrospectively, return, reuptake, royalty, sale, security, selective, sell, shell, SNRI, software, standard, submitting, subsequent, succeeded, supported, surviving, tabular, terminated, termination, thereunto, threshold, uncertainty, undersigned, unobservable, upfront

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Bionovo similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Chapter 63, Title 18 U.S.C. Section 1350(A) and (B))

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chapter 63, Title 18 U.S.C. Section 1350(a) and (b)), the undersigned hereby certifies in his capacity as an officer of Bionovo, Inc. (the “Company”) that the Quarterly Report of the Company on Form 10-Q for the period ended March 31, 2009, fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended, and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of the Company at the end of and for the periods covered by such Report.



/s/ Isaac Cohen Isaac Cohen Chairman of the Board and Chief Executive Officer		/s/ Thomas C. Chesterman Thomas C. Chesterman Senior Vice President and Chief Financial Officer

Dated: May 7, 2009		Dated: May 7, 2009

*This certification will not be deemed filed for purposes of Section 18 of the Exchange Act (15 U.S.C. 78), or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.